Citadel Advisors
NBP

Citadel Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Citadel Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
622,831
+456,215
+274% +$930K ﹤0.01% 7726
2026
Q1 		$410K Buy
+166,616
New +$558K ﹤0.01% 9765
2025
Q1 		– Sell
-931
Closed -$884 – 14988
2024
Q4 		$791 Sell
931
-97,458
-99% -$108K ﹤0.01% 14269
2024
Q3 		$122K Buy
98,389
+59,681
+154% +$74.7K ﹤0.01% 10852
2024
Q2 		$64.6K Buy
+38,708
New +$69.2K ﹤0.01% 11473
2024
Q1 		– Sell
-74,029
Closed -$136K – 14991
2023
Q4 		$141K Buy
+74,029
New +$111K ﹤0.01% 10482
2023
Q3 		– Sell
-485
Closed -$1.06K – 14659
2023
Q2 		$1.45K Sell
485
-109,822
-100% -$353K ﹤0.01% 13933
2023
Q1 		$382K Sell
110,307
-80,326
-42% -$389K ﹤0.01% 8866
2022
Q4 		$797K Sell
190,633
-437,074
-70% -$1.65M ﹤0.01% 7260
2022
Q3 		$2.52M Buy
627,707
+602,966
+2,437% +$4.57M ﹤0.01% 5150
2022
Q2 		$280K Buy
+24,741
New +$297K ﹤0.01% 9951
2022
Q1 		– Sell
-29,130
Closed -$746K – 14051
2021
Q4 		$1.38M Sell
29,130
-20,116
-41% -$1.21M ﹤0.01% 7080
2021
Q3 		$3.57M Buy
49,246
+40,018
+434% +$2.89M ﹤0.01% 4981
2021
Q2 		$775K Buy
9,228
+4,084
+79% +$269K ﹤0.01% 9025
2021
Q1 		$249K Sell
5,144
-71,847
-93% -$3.9M ﹤0.01% 11244
2020
Q4 		$3.63M Buy
+76,991
New +$3.03M ﹤0.01% 4250

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's NBP Position: Q2 2026 in Review

Citadel Advisors increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 274% in Q2 2026, buying an estimated $930K and bringing the position to 622,831 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7726.

Citadel Advisors first reported a position in NBP in Q4 2020 and has held it in 16 quarters since. The position peaked at $3.63M in Q4 2020. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Citadel Advisors held 622,831 shares of NovaBridge Biosciences American Depositary Shares worth $1.21M as of Q2 2026.
  • Citadel Advisors bought 456,215 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $930K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7726 holding.
  • Citadel Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 16 quarters since.
  • Citadel Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $3.63M in Q4 2020.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.